Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Bicara Therapeutics Inc. Common Stock Share Price

BCAX

NMQ

$14.49

+$0.41

(2.91%)

Industry: Biotechnology Sector: Health Care

Bicara Therapeutics Inc. Common Stock Analyst Forecast

Overview Returns Financials Ratios News FAQs

Bicara Therapeutics Inc. Common Stock Share Price Chart

Bicara Therapeutics Inc. Common Stock Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$771.33M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

2.6171

Volume

This is the total number of shares traded during the most recent trading day.

365.14K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$7.8 L

$19.71 H

$14.49

About Bicara Therapeutics Inc. Common Stock, Common Stock

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Bicara Therapeutics Inc. Common Stock Stock Returns

Time Frame	BCAX	Sector	S&P500
1-Week Return	-4.86%	0.72%	-1.31%
1-Month Return	-15.79%	1.27%	0.78%
3-Month Return	-9.57%	3.13%	3.46%
6-Month Return	22.76%	15.81%	6.19%
1-Year Return	7.56%	8.89%	11.68%
3-Year Return	-21.78%	20.79%	71.21%

Time Frame	BCAX	Sector	S&P500
1-Week Return	-92.56%	45.37%	-49.72%
1-Month Return	-87.64%	16.60%	9.91%
3-Month Return	-33.50%	13.31%	14.79%
6-Month Return	51.56%	34.67%	12.95%
1-Year Return	7.56%	8.89%	11.68%
3-Year Return	-7.86%	6.50%	19.63%

Bicara Therapeutics Inc. Common Stock Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	10.00K	19.00K	56.00K	[{"date":"2022-12-31","value":17.86,"profit":true},{"date":"2023-12-31","value":33.93,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	(10.00K)	(19.00K)	(56.00K)	[{"date":"2022-12-31","value":-1000000,"profit":false},{"date":"2023-12-31","value":-1900000,"profit":false},{"date":"2024-12-31","value":-5600000,"profit":false}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	37.66M	39.89M	82.39M	[{"date":"2022-12-31","value":45.71,"profit":true},{"date":"2023-12-31","value":48.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(37.66M)	(39.89M)	(82.39M)	[{"date":"2022-12-31","value":-3765600000,"profit":false},{"date":"2023-12-31","value":-3988900000,"profit":false},{"date":"2024-12-31","value":-8238900000,"profit":false}]
Total Non-Operating Income/Expense	(296.00K)	(10.78M)	29.16M	[{"date":"2022-12-31","value":-1.02,"profit":false},{"date":"2023-12-31","value":-36.96,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(37.84M)	(51.98M)	(67.81M)	[{"date":"2022-12-31","value":-3784400000,"profit":false},{"date":"2023-12-31","value":-5198000000,"profit":false},{"date":"2024-12-31","value":-6780800000,"profit":false}]
Income Taxes	1.00K	5.00K	187.00K	[{"date":"2022-12-31","value":0.53,"profit":true},{"date":"2023-12-31","value":2.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	(37.84M)	(51.98M)	(68.00M)	[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]

Income From Continuous Operations	(37.84M)	(51.98M)	(68.00M)	[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(37.84M)	(51.98M)	(68.00M)	[{"date":"2022-12-31","value":-3784500000,"profit":false},{"date":"2023-12-31","value":-5198500000,"profit":false},{"date":"2024-12-31","value":-6799500000,"profit":false}]

EPS (Diluted)	-	-	(2.44)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-244,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	90.00%	194.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":46.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	90.00%	194.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":46.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	5.93%	106.55%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":5.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	5.93%	106.55%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":5.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	3540.88%	(370.59%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-10.47,"profit":false}]
Pre-Tax Income	-	37.35%	30.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":81.52,"profit":true}]
Income Taxes	-	400.00%	3640.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":10.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	-	37.36%	30.80%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":82.43,"profit":true}]

Income From Continuous Operations	-	37.36%	30.80%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":82.43,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	37.36%	30.80%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":82.43,"profit":true}]

EPS (Diluted)	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	15.00K	15.00K	19.00K	19.00K	-	[{"date":"2024-09-30","value":78.95,"profit":true},{"date":"2024-12-31","value":78.95,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	(15.00K)	(15.00K)	(19.00K)	(19.00K)	-	[{"date":"2024-09-30","value":-1500000,"profit":false},{"date":"2024-12-31","value":-1500000,"profit":false},{"date":"2025-03-31","value":-1900000,"profit":false},{"date":"2025-06-30","value":-1900000,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	20.63M	26.64M	41.79M	32.02M	40.68M	[{"date":"2024-09-30","value":49.36,"profit":true},{"date":"2024-12-31","value":63.74,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":76.62,"profit":true},{"date":"2025-09-30","value":97.34,"profit":true}]
Operating Income	(20.63M)	(26.64M)	(41.79M)	(32.02M)	(40.68M)	[{"date":"2024-09-30","value":-2062800000,"profit":false},{"date":"2024-12-31","value":-2663700000,"profit":false},{"date":"2025-03-31","value":-4178800000,"profit":false},{"date":"2025-06-30","value":-3201800000,"profit":false},{"date":"2025-09-30","value":-4067600000,"profit":false}]
Total Non-Operating Income/Expense	6.29M	11.73M	10.03M	9.36M	8.77M	[{"date":"2024-09-30","value":53.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":85.48,"profit":true},{"date":"2025-06-30","value":79.82,"profit":true},{"date":"2025-09-30","value":74.77,"profit":true}]
Pre-Tax Income	(17.48M)	(20.77M)	(36.77M)	(27.34M)	(36.29M)	[{"date":"2024-09-30","value":-1748100000,"profit":false},{"date":"2024-12-31","value":-2077100000,"profit":false},{"date":"2025-03-31","value":-3677400000,"profit":false},{"date":"2025-06-30","value":-2733600000,"profit":false},{"date":"2025-09-30","value":-3629000000,"profit":false}]
Income Taxes	-	186.00K	72.00K	52.00K	40.00K	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":38.71,"profit":true},{"date":"2025-06-30","value":27.96,"profit":true},{"date":"2025-09-30","value":21.51,"profit":true}]
Income After Taxes	-	(20.96M)	(36.85M)	(27.39M)	(36.33M)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-2095700000,"profit":false},{"date":"2025-03-31","value":-3684600000,"profit":false},{"date":"2025-06-30","value":-2738800000,"profit":false},{"date":"2025-09-30","value":-3633000000,"profit":false}]

Income From Continuous Operations	(17.48M)	(20.96M)	(36.85M)	(27.39M)	(36.33M)	[{"date":"2024-09-30","value":-1748100000,"profit":false},{"date":"2024-12-31","value":-2095700000,"profit":false},{"date":"2025-03-31","value":-3684600000,"profit":false},{"date":"2025-06-30","value":-2738800000,"profit":false},{"date":"2025-09-30","value":-3633000000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(17.48M)	(20.96M)	(36.85M)	(27.39M)	(36.33M)	[{"date":"2024-09-30","value":-1748100000,"profit":false},{"date":"2024-12-31","value":-2095700000,"profit":false},{"date":"2025-03-31","value":-3684600000,"profit":false},{"date":"2025-06-30","value":-2738800000,"profit":false},{"date":"2025-09-30","value":-3633000000,"profit":false}]

EPS (Diluted)	(1.60)	(0.39)	(0.68)	(0.50)	(0.67)	[{"date":"2024-09-30","value":-160,"profit":false},{"date":"2024-12-31","value":-39,"profit":false},{"date":"2025-03-31","value":-68,"profit":false},{"date":"2025-06-30","value":-50,"profit":false},{"date":"2025-09-30","value":-67,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	-	26.67%	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	-	26.67%	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	29.13%	56.88%	(23.38%)	27.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":51.21,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-41.1,"profit":false},{"date":"2025-09-30","value":47.54,"profit":true}]
Operating Income	-	29.13%	56.88%	(23.38%)	27.04%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":51.21,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-41.1,"profit":false},{"date":"2025-09-30","value":47.54,"profit":true}]
Total Non-Operating Income/Expense	-	86.40%	(14.52%)	(6.62%)	(6.32%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-16.81,"profit":false},{"date":"2025-06-30","value":-7.66,"profit":false},{"date":"2025-09-30","value":-7.32,"profit":false}]
Pre-Tax Income	-	18.82%	77.04%	(25.66%)	32.76%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":24.43,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-33.31,"profit":false},{"date":"2025-09-30","value":42.51,"profit":true}]
Income Taxes	-	-	(61.29%)	(27.78%)	(23.08%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income After Taxes	-	-	75.82%	(25.67%)	32.65%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-33.86,"profit":false},{"date":"2025-09-30","value":43.06,"profit":true}]

Income From Continuous Operations	-	19.88%	75.82%	(25.67%)	32.65%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":26.23,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-33.86,"profit":false},{"date":"2025-09-30","value":43.06,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	19.88%	75.82%	(25.67%)	32.65%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":26.23,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-33.86,"profit":false},{"date":"2025-09-30","value":43.06,"profit":true}]

EPS (Diluted)	-	(75.63%)	74.36%	(26.47%)	34.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-101.7,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-35.6,"profit":false},{"date":"2025-09-30","value":45.72,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	4.98M	231.07M	502.53M	[{"date":"2022-12-31","value":0.99,"profit":true},{"date":"2023-12-31","value":45.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	1.72M	2.91M	66.66M	[{"date":"2022-12-31","value":2.58,"profit":true},{"date":"2023-12-31","value":4.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	6.70M	233.98M	569.20M	[{"date":"2022-12-31","value":1.18,"profit":true},{"date":"2023-12-31","value":41.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	23.90M	15.09M	17.99M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.13,"profit":true},{"date":"2024-12-31","value":75.28,"profit":true}]
Non-current Liabilities	85.00K	389.00K	59.33M	[{"date":"2022-12-31","value":0.14,"profit":true},{"date":"2023-12-31","value":0.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	23.98M	15.47M	77.32M	[{"date":"2022-12-31","value":31.02,"profit":true},{"date":"2023-12-31","value":20.01,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	2.00K	2.00K	7.00K	[{"date":"2022-12-31","value":28.57,"profit":true},{"date":"2023-12-31","value":28.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(101.04M)	(153.02M)	(221.02M)	[{"date":"2022-12-31","value":-10103600000,"profit":false},{"date":"2023-12-31","value":-15302100000,"profit":false},{"date":"2024-12-31","value":-22101600000,"profit":false}]
Other Stockholders' Equity	2.23M	4.25M	712.88M	[{"date":"2022-12-31","value":0.31,"profit":true},{"date":"2023-12-31","value":0.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(17.28M)	218.51M	491.88M	[{"date":"2022-12-31","value":-3.51,"profit":false},{"date":"2023-12-31","value":44.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	6.70M	233.98M	569.20M	[{"date":"2022-12-31","value":1.18,"profit":true},{"date":"2023-12-31","value":41.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	4536.30%	117.48%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.59,"profit":true}]
Non-current Assets	-	69.23%	2191.58%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":3.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	3390.71%	143.26%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":4.23,"profit":true}]

Total Liabilities
Current Liabilities	-	(36.87%)	19.26%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-191.47,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	357.65%	15151.93%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":2.36,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	(35.47%)	399.68%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-8.88,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	250.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	51.45%	44.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.36,"profit":true}]
Other Stockholders' Equity	-	90.50%	16673.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":0.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(1364.66%)	125.11%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-1090.8,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	3390.71%	143.26%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":4.23,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	521.51M	502.53M	470.75M	444.39M	297.37M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":96.36,"profit":true},{"date":"2025-03-31","value":90.27,"profit":true},{"date":"2025-06-30","value":85.21,"profit":true},{"date":"2025-09-30","value":57.02,"profit":true}]
Non-current Assets	2.66M	66.66M	7.32M	9.20M	127.32M	[{"date":"2024-09-30","value":2.09,"profit":true},{"date":"2024-12-31","value":52.36,"profit":true},{"date":"2025-03-31","value":5.75,"profit":true},{"date":"2025-06-30","value":7.22,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	524.17M	569.20M	478.08M	453.59M	424.69M	[{"date":"2024-09-30","value":92.09,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":83.99,"profit":true},{"date":"2025-06-30","value":79.69,"profit":true},{"date":"2025-09-30","value":74.61,"profit":true}]

Total Liabilities
Current Liabilities	14.48M	17.99M	19.12M	17.23M	21.03M	[{"date":"2024-09-30","value":68.87,"profit":true},{"date":"2024-12-31","value":85.55,"profit":true},{"date":"2025-03-31","value":90.93,"profit":true},{"date":"2025-06-30","value":81.92,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	137.00K	59.33M	-	1.16M	880.00K	[{"date":"2024-09-30","value":0.23,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":1.96,"profit":true},{"date":"2025-09-30","value":1.48,"profit":true}]
Total Liabilities	14.62M	77.32M	19.12M	18.39M	21.91M	[{"date":"2024-09-30","value":18.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":24.73,"profit":true},{"date":"2025-06-30","value":23.79,"profit":true},{"date":"2025-09-30","value":28.33,"profit":true}]

Total Shareholders' equity
Common Stock	7.00K	7.00K	7.00K	7.00K	7.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(200.06M)	(221.02M)	(257.86M)	(285.25M)	(321.58M)	[{"date":"2024-09-30","value":-20005900000,"profit":false},{"date":"2024-12-31","value":-22101600000,"profit":false},{"date":"2025-03-31","value":-25786200000,"profit":false},{"date":"2025-06-30","value":-28525000000,"profit":false},{"date":"2025-09-30","value":-32158000000,"profit":false}]
Other Stockholders' Equity	709.61M	712.88M	716.81M	720.44M	724.49M	[{"date":"2024-09-30","value":97.95,"profit":true},{"date":"2024-12-31","value":98.4,"profit":true},{"date":"2025-03-31","value":98.94,"profit":true},{"date":"2025-06-30","value":99.44,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	509.56M	491.88M	458.96M	435.20M	402.78M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":96.53,"profit":true},{"date":"2025-03-31","value":90.07,"profit":true},{"date":"2025-06-30","value":85.41,"profit":true},{"date":"2025-09-30","value":79.05,"profit":true}]

Total Liabilities & Shareholders Equity	524.17M	569.20M	478.08M	453.59M	424.69M	[{"date":"2024-09-30","value":92.09,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":83.99,"profit":true},{"date":"2025-06-30","value":79.69,"profit":true},{"date":"2025-09-30","value":74.61,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(3.64%)	(6.32%)	(5.60%)	(33.08%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	2407.03%	(89.01%)	25.58%	1284.47%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-3.7,"profit":false},{"date":"2025-06-30","value":1.06,"profit":true},{"date":"2025-09-30","value":53.36,"profit":true}]
Total Assets	-	8.59%	(16.01%)	(5.12%)	(6.37%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-186.38,"profit":false},{"date":"2025-06-30","value":-59.64,"profit":false},{"date":"2025-09-30","value":-74.18,"profit":false}]

Total Liabilities
Current Liabilities	-	24.23%	6.28%	(9.90%)	22.06%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":25.92,"profit":true},{"date":"2025-06-30","value":-40.86,"profit":false},{"date":"2025-09-30","value":91.05,"profit":true}]
Non-current Liabilities	-	43206.57%	-	-	(24.40%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":-0.06,"profit":false}]
Total Liabilities	-	428.94%	(75.27%)	(3.81%)	19.12%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-17.55,"profit":false},{"date":"2025-06-30","value":-0.89,"profit":false},{"date":"2025-09-30","value":4.46,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	10.48%	16.67%	10.62%	12.74%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":62.84,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":63.71,"profit":true},{"date":"2025-09-30","value":76.4,"profit":true}]
Other Stockholders' Equity	-	0.46%	0.55%	0.51%	0.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":82.15,"profit":true},{"date":"2025-03-31","value":98.02,"profit":true},{"date":"2025-06-30","value":90.01,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	(3.47%)	(6.69%)	(5.18%)	(7.45%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	8.59%	(16.01%)	(5.12%)	(6.37%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-186.38,"profit":false},{"date":"2025-06-30","value":-59.64,"profit":false},{"date":"2025-09-30","value":-74.18,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(32.08M)	(45.63M)	(74.75M)	[{"date":"2022-12-31","value":-3207600000,"profit":false},{"date":"2023-12-31","value":-4562800000,"profit":false},{"date":"2024-12-31","value":-7475100000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(192.00K)	(586.00K)	(9.00K)	[{"date":"2022-12-31","value":-19200000,"profit":false},{"date":"2023-12-31","value":-58600000,"profit":false},{"date":"2024-12-31","value":-900000,"profit":false}]

Financing Activities
Net Financing Cash Flow	31.70M	272.50M	334.03M	[{"date":"2022-12-31","value":9.49,"profit":true},{"date":"2023-12-31","value":81.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	(573.00K)	226.28M	259.27M	[{"date":"2022-12-31","value":-0.22,"profit":false},{"date":"2023-12-31","value":87.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(32.27M)	(46.21M)	(74.82M)	[{"date":"2022-12-31","value":-3226800000,"profit":false},{"date":"2023-12-31","value":-4621400000,"profit":false},{"date":"2024-12-31","value":-7482200000,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	42.25%	63.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":66.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	205.21%	(98.46%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-47.98,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	759.74%	22.58%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.97,"profit":true}]

Net Change in Cash	-	(39590.75%)	14.58%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-271565.5,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	43.22%	61.90%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":69.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(17.22M)	(30.03M)	(28.11M)	(25.59M)	(29.25M)	[{"date":"2024-09-30","value":-1722400000,"profit":false},{"date":"2024-12-31","value":-3003200000,"profit":false},{"date":"2025-03-31","value":-2810600000,"profit":false},{"date":"2025-06-30","value":-2559400000,"profit":false},{"date":"2025-09-30","value":-2924800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(8.00K)	(40.00K)	-	-	(236.12M)	[{"date":"2024-09-30","value":-800000,"profit":false},{"date":"2024-12-31","value":-4000000,"profit":false},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":-23612100000,"profit":false}]

Financing Activities
Net Financing Cash Flow	334.13M	(975.00K)	460.00K	135.00K	436.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-0.29,"profit":false},{"date":"2025-03-31","value":0.14,"profit":true},{"date":"2025-06-30","value":0.04,"profit":true},{"date":"2025-09-30","value":0.13,"profit":true}]

Net Change in Cash	316.90M	(31.05M)	(27.65M)	(25.46M)	(264.93M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-9.8,"profit":false},{"date":"2025-03-31","value":-8.72,"profit":false},{"date":"2025-06-30","value":-8.03,"profit":false},{"date":"2025-09-30","value":-83.6,"profit":false}]

Free Cash Flow
Free Cash Flow	(17.23M)	(30.07M)	(28.11M)	(25.59M)	(29.29M)	[{"date":"2024-09-30","value":-1723200000,"profit":false},{"date":"2024-12-31","value":-3007200000,"profit":false},{"date":"2025-03-31","value":-2810600000,"profit":false},{"date":"2025-06-30","value":-2559400000,"profit":false},{"date":"2025-09-30","value":-2929000000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	74.36%	(6.41%)	(8.94%)	14.28%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-8.62,"profit":false},{"date":"2025-06-30","value":-12.02,"profit":false},{"date":"2025-09-30","value":19.2,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	400.00%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(100.29%)	(147.18%)	(70.65%)	222.96%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-44.98,"profit":false},{"date":"2025-03-31","value":-66.01,"profit":false},{"date":"2025-06-30","value":-31.69,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(109.80%)	(10.95%)	(7.91%)	940.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-11.67,"profit":false},{"date":"2025-03-31","value":-1.16,"profit":false},{"date":"2025-06-30","value":-0.84,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	74.51%	(6.54%)	(8.94%)	14.44%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-8.77,"profit":false},{"date":"2025-06-30","value":-11.99,"profit":false},{"date":"2025-09-30","value":19.38,"profit":true}]

Bicara Therapeutics Inc. Common Stock Ratios

Bicara Therapeutics Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BCAX
Cash Ratio	13.80
Current Ratio	14.14

Bicara Therapeutics Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BCAX
ROA (LTM)	-18.59%
ROE (LTM)	-26.64%

Bicara Therapeutics Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BCAX
Debt Ratio Lower is generally better. Negative is bad.	0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.95

Bicara Therapeutics Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BCAX
Trailing PE	2.62
Forward PE	NM
P/S (TTM)	0.00
P/B	1.93
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Bicara Therapeutics Inc. Common Stock share price today?

Bicara Therapeutics Inc. Common Stock (BCAX) share price today is $14.49

Can Indians buy Bicara Therapeutics Inc. Common Stock shares?

Yes, Indians can buy shares of Bicara Therapeutics Inc. Common Stock (BCAX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bicara Therapeutics Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Bicara Therapeutics Inc. Common Stock (BCAX) via the Vested app. You can start investing in Bicara Therapeutics Inc. Common Stock (BCAX) with a minimum investment of $1.

How to invest in Bicara Therapeutics Inc. Common Stock shares from India?

You can invest in shares of Bicara Therapeutics Inc. Common Stock (BCAX) via Vested in three simple steps:

Click on Sign Up or Invest in BCAX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Bicara Therapeutics Inc. Common Stock shares

What is Bicara Therapeutics Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Bicara Therapeutics Inc. Common Stock (BCAX) is $19.71. The 52-week low price of Bicara Therapeutics Inc. Common Stock (BCAX) is $7.8.

What is Bicara Therapeutics Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bicara Therapeutics Inc. Common Stock (BCAX) is 2.6171

What is Bicara Therapeutics Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bicara Therapeutics Inc. Common Stock (BCAX) is 1.93

What is Bicara Therapeutics Inc. Common Stock dividend yield?

The dividend yield of Bicara Therapeutics Inc. Common Stock (BCAX) is 0.00%

What is the Market Cap of Bicara Therapeutics Inc. Common Stock?

The market capitalization of Bicara Therapeutics Inc. Common Stock (BCAX) is $771.33M

What is Bicara Therapeutics Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Bicara Therapeutics Inc. Common Stock is BCAX

How Can Investors Use Bicara Therapeutics Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Bicara Therapeutics Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Bicara Therapeutics Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Bicara Therapeutics Inc. Common Stock shares for Indian investors?

When investing in Bicara Therapeutics Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Bicara Therapeutics Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Bicara Therapeutics Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Bicara Therapeutics Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Bicara Therapeutics Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Bicara Therapeutics Inc. Common Stock Share Price

Bicara Therapeutics Inc. Common Stock Analyst Forecast

Bicara Therapeutics Inc. Common Stock Share Price Chart

Bicara Therapeutics Inc. Common Stock Key Stock Metrics

About Bicara Therapeutics Inc. Common Stock, Common Stock

Bicara Therapeutics Inc. Common Stock Stock Returns

Bicara Therapeutics Inc. Common Stock Financials

Bicara Therapeutics Inc. Common Stock Ratios

Bicara Therapeutics Inc. Common Stock Liquidity Ratios

Bicara Therapeutics Inc. Common Stock Asset Efficiency Ratios

Bicara Therapeutics Inc. Common Stock Liability Ratios

Bicara Therapeutics Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Bicara Therapeutics Inc. Common Stock Share Price

Bicara Therapeutics Inc. Common Stock Analyst Forecast

Bicara Therapeutics Inc. Common Stock Share Price Chart

Bicara Therapeutics Inc. Common Stock Key Stock Metrics

About Bicara Therapeutics Inc. Common Stock, Common Stock

Bicara Therapeutics Inc. Common Stock Stock Returns

Bicara Therapeutics Inc. Common Stock Financials

Bicara Therapeutics Inc. Common Stock Ratios

Bicara Therapeutics Inc. Common Stock Liquidity Ratios

Bicara Therapeutics Inc. Common Stock Asset Efficiency Ratios

Bicara Therapeutics Inc. Common Stock Liability Ratios

Bicara Therapeutics Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²